摘要
目的评价慢性肝病患者自评量表的信度、效度及反应度。方法以慢性乙型肝炎、慢性丙型肝炎、酒精性肝炎、脂肪性肝炎、肝硬化代偿期为研究对象,应用我们以往研究编制的慢性肝病患者自评量表进行测评。共纳入患者104例,与51例正常人对照,进行信度、效度、反应度分析,并对慢性肝病患者与正常人、慢性乙肝患者与其他肝病患者进行对比分析。结果该量表总体克朗巴赫α系数为0.915,总体Guttman折半系数0.703;该量表KMO统计量为0.783,Bartlett球形检验卡方值1801.149(P<0.001),主成分因子分析方法提取特征根值>1的8个公因子,累计贡献率为69.636%;以t检验方法分别分析慢性肝病患者与正常人、慢性乙肝患者与其他肝病患者量表总分,P值分别为0.000、0.413。结论该量表有较好的信度、效度及反应度,可作为慢性肝病患者临床疗效的评价工具。
Objective To explore the reliability, validity and reaction degree of patient reported outcome instrument for chronic hepatitis diseases. Methods One hundred and four cases with chronic 13 hepatitis, chronic C hepatitis, alcoholic liver disease, steatohepatitis and decompensated cirrhosis were included and tested by patient reported outcome instrument for chronic hepatitis diseases and compared with 51 normal people. The reliability, validity and reaction degree were analyzed. The chronic hepatitis patient and normal people, chronic B hepatitis and other patients with liver disease were compared. Result The total Cronbach＇s Alpha of the instrument was 0.915, the total split-half reliability was 0.703, the KMO value was 0.783, Bartlett test value was 1 801.149 （P〈0.001）, factor analysis resulted in 8 factors with eigenvalue 〉 1, which contributed to 69.636%. The chronic hepatitis patients and normal people, chronic B Hepatitis patients and others were analyzed respectively by T test, P value were 0.000 and 0.413 respectively. Conclusion The instrument has a good internal reliability, validity and reaction degree, which can be applied for the therapeutic evaluation of chronic hepertafis diseases.
出处
《中国中医药信息杂志》
CAS
CSCD
2010年第6期13-15,共3页
Chinese Journal of Information on Traditional Chinese Medicine
关键词
慢性肝病
自评量表
信度
效度
反应度
chronic hepatitis diseases
patients reported outcome
scale
reliability
validity
reaction degree
